TNFRSF13C Antikörper (PE-Cy7)
Kurzübersicht für TNFRSF13C Antikörper (PE-Cy7) (ABIN740773)
Target
Alle TNFRSF13C Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat,Dog,Cow,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human BAFFR
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM(1:100-500)
Optimal working dilution should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- TNFRSF13C (Tumor Necrosis Factor Receptor Superfamily, Member 13C (TNFRSF13C))
-
Andere Bezeichnung
- BAFFR/CD268
-
Hintergrund
-
Synonyms: BAFFR, CD268, CVID4, BAFF-R, BROMIX, prolixin, Tumor necrosis factor receptor superfamily member 13C, B-cell-activating factor receptor, BAFF receptor, BLyS receptor 3, TNFRSF13C, BR3
Background: B-cell receptor specific for TNFSF13B/TALL1/BAFF/BLyS. Promotes the survival of mature B-cells and the B-cell response.
-
Molekulargewicht
- 20kDa
-
Gen-ID
- 115650
-
UniProt
- Q96RJ3
-
Pathways
- NF-kappaB Signalweg
Target
-